Cabot Brown is Director at GW PHARMACEUTICALS PLC (GWPH). They have made 4 open-market trades across 1 company since 2019, most recently 2021-05-05.
CIK 0001754153
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GWPH | 7,200 | $1.6M |
Shares reported on the most recent Form 4, priced at the 2021-03-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GWPH | SELL | 2021-03-18 | 2021-03-22 | $17.95 | $72K | +0.9% | +1.4% | N/A |
| GWPH | SELL | 2020-03-02 | 2020-03-04 | $8.24 | $26K | -28.2% | -18.9% | +26.2% |
| GWPH | SELL · 10b5-1 | 2020-01-03 | 2020-01-07 | $8.58 | $31K | +16.7% | +16.0% | -15.1% |
| GWPH | SELL | 2019-03-01 | 2019-03-05 | $14.38 | $749K | -1.7% | -6.1% | +2.0% |
| GWPH | SELL | 2019-03-01 | 2019-03-05 | $14.38 | $749K | -1.7% | -6.1% | +2.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.